Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial
- DOI
- 10.1200/po-26-00323
- Published
- 2026-09
- Container
- JCO Precision Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/po-26-00323,
title = {Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial},
author = {Chi Leung Chiang and Sik Kwan Kenneth Chan and Ann Shing Francis Lee and Ka Ming Eric Lam and Chun Yin Edwin Wong and Chun Wan Dominic Chan and Kwan Shuen Kristy Chan and Stephen Li and Wing Hon Jason Wong and Wan Hang Keith Chiu and Cheuk Lam Regina Lo},
year = {2026},
journal = {JCO Precision Oncology},
doi = {10.1200/po-26-00323},
url = {https://doi.org/10.1200/po-26-00323}
}RIS
TY - JOUR TI - Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial AU - Chi Leung Chiang AU - Sik Kwan Kenneth Chan AU - Ann Shing Francis Lee AU - Ka Ming Eric Lam AU - Chun Yin Edwin Wong AU - Chun Wan Dominic Chan AU - Kwan Shuen Kristy Chan AU - Stephen Li AU - Wing Hon Jason Wong AU - Wan Hang Keith Chiu AU - Cheuk Lam Regina Lo PY - 2026 JO - JCO Precision Oncology DO - 10.1200/po-26-00323 UR - https://doi.org/10.1200/po-26-00323 ER -
APA
Chiang, C. L., Chan, S. K. K., Lee, A. S. F., Lam, K. M. E., Wong, C. Y. E., Chan, C. W. D., Chan, K. S. K., Li, S., Wong, W. H. J., Chiu, W. H. K., & Lo, C. L. R. (2026). Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II Trial. JCO Precision Oncology. https://doi.org/10.1200/po-26-00323
Source records
- crossref · retrieved 2026-09-25T08:51:58.301Z